Confidential Disclosure Agreement In Clinical Research Template for Saudi Arabia

Generate a bespoke document

Trusted by 200k+ teams

4.7 Capterra
4.8 Product Hunt
4.6 Trustpilot

What is a Confidential Disclosure Agreement In Clinical Research?

The Confidential Disclosure Agreement in Clinical Research is essential for protecting sensitive information in clinical trials and medical research conducted in Saudi Arabia. This document is typically used when research institutions, pharmaceutical companies, or healthcare providers need to share confidential information for clinical trials, research collaboration, or medical studies. It ensures compliance with Saudi Food and Drug Authority (SFDA) regulations, the Saudi Personal Data Protection Law, and Islamic law principles. The agreement covers various types of confidential information including patient data, research protocols, trial methodologies, and preliminary results. It's particularly important in the Saudi Arabian context where healthcare data protection and research ethics must align with both international standards and local regulatory requirements. The document includes specific provisions for data handling, security measures, and confidentiality obligations that meet SFDA guidelines while facilitating necessary information sharing for clinical research advancement.

Reviewed by

Swetha Meenal

Legal Engineer, GenieAI

Swetha Meenal profile photo

A lawyer, legal researcher and legal tech founder, Swetha has built AI products deployed inside Tier 1 firms and enterprises. She ensures GenieAI's alignment with the latest regulation and executes testing on the legal robustness of Genie output.

Reviewed by

Imad Mohammed Nazar

Legal Engineer, GenieAI

Imad Mohammed Nazar profile photo

A Skadden-trained M&A lawyer, Imad advised on cross-border transactions and contractual risk before moving into legal AI. He reviews GenieAI's output for compliance and enforceability across our 150+ supported jurisdictions, as well as facilitating external benchmarking.

Jurisdiction

Saudi Arabia

Publisher

GenieAI

Sector

Business

Cost

Free to use

Last updated

About the Confidential Disclosure Agreement In Clinical Research

A Confidential Disclosure Agreement in Clinical Research is a crucial legal document that protects sensitive information when you're involved in medical research or clinical trials in Saudi Arabia. This agreement creates binding legal obligations between parties to maintain confidentiality of shared research data, patient information, trial protocols, and other proprietary medical information while enabling necessary collaboration for clinical research advancement.

When do you need this document?

You need this agreement when establishing partnerships for clinical trials between pharmaceutical companies and research institutions, sharing patient data with contract research organizations for study analysis, or collaborating with hospitals on multi-site clinical studies. It's essential when biotechnology companies partner with academic medical institutions for drug development research, medical device manufacturers work with clinical trial sites for product testing, or healthcare data analytics companies access clinical databases for research purposes. The agreement is also required when individual research investigators collaborate across institutions or when sharing preliminary research findings with potential commercial partners.

Key legal considerations

Your agreement must clearly define what constitutes confidential information, including patient data, research protocols, trial methodologies, statistical analyses, and preliminary results. You need specific clauses addressing data security measures, including encryption requirements, access controls, and breach notification procedures. The document should establish the permitted uses of confidential information, restrictions on disclosure to third parties, and obligations for return or destruction of information upon termination. Consider including provisions for intellectual property rights, publication restrictions, and survival of confidentiality obligations beyond the agreement's termination. You should also address liability limitations, indemnification clauses, and dispute resolution mechanisms that comply with Saudi legal requirements.

Legal requirements in Saudi Arabia

Your agreement must comply with Saudi Food and Drug Authority Clinical Trial Regulations, which mandate specific data handling and confidentiality requirements for clinical research conducted in the Kingdom. Under the Saudi Personal Data Protection Law enacted in 2021, you must implement appropriate technical and organizational measures to protect personal health information and ensure lawful processing of sensitive medical data. The agreement must align with the Law of Healthcare Professions, which establishes confidentiality obligations for healthcare professionals involved in medical research. All contractual provisions must conform to Saudi Civil Transactions Law and Sharia principles, ensuring the agreement is enforceable under Islamic law. You should include compliance with the Saudi Electronic Transactions Law if digital signatures or electronic data transfers are involved, and ensure the agreement meets international clinical research standards while respecting local cultural and religious considerations in healthcare data handling.

Genie's Security Promise

Genie is the safest place to draft. Here's how we prioritise your privacy and security.

Your data is private:

We do not train on your data; Genie's AI improves independently

All data stored on Genie is private to your organisation

Your documents are protected:

Your documents are protected by ultra-secure 256-bit encryption

We are ISO27001 certified, so your data is secure

Organizational security:

You retain IP ownership of your documents and their information

You have full control over your data and who gets to see it